Fusion protein of thymosin α1 and IgY Fc, recombinant expression vector and engineering bacteria and their application
By constructing a fusion protein expressing thymosin α1 and IgY Fc and using Lactococcus lactis as feed additives in the breeding industry, the health problems caused by the use of antibiotics in the breeding industry and the high cost of extracting thymosin α1 are solved, and animal immunity is improved Effects of strength and survival rate.
Patent Information
- Application Number
- CN202311697915.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-12
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2043-12-12
AI Technical Summary
When the prior art uses antibiotics and chemical drugs to prevent diseases in the breeding industry, it reduces the activity of animal intestinal flora and increases the risk of pathogen transmission. The extraction and chemical synthesis of thymic peptide α1 are costly and difficult to apply.
By constructing a recombinant expression vector of fusion proteins expressing thymic peptide α1 and IgY Fc, and using Lactococcus lactis as a genetically engineered host, it is successfully expressed and colonized in the intestines of animals, providing a safe and low-cost feed additive to improve animal immunity strength and survival rate.
It has achieved improved animal immunity and survival rate, reduced inflammatory response, reduced production costs, and has higher purity and safety compared with traditional methods. It is suitable for breeding of various animals.
Smart Images

Figure CN117659213B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of genetic engineering, and specifically relates to a fusion protein of thymosin alpha 1 and IgY Fc, a recombinant expression vector and an engineering bacterium and applications thereof. Background Art
[0002] my country is a large agricultural country. As an important part of my country's agriculture, the development of animal husbandry has a great impact on the development of my country's agricultural economy. Animal husbandry plays an increasingly important role in improving the sustainability of global livestock production. However, the intensive development of animal husbandry increases the risk of farmed species being infected with pathogens. While antibiotics, fungicides and chemical drugs prevent and treat diseases, they also reduce the activity of beneficial microorganisms in the intestinal flora, change the microecological system of organisms, interfere with the nutrition, physiological processes and immune capacity of animals, and increase the risk of pathogens and harmful compounds spreading to consumers. Therefore, alternative methods are urgently needed to deal with the threat of pathogens in animal husbandry.
[0003] Thymosin α1 is isolated from the thymus of healthy cows and pigs and contains a variety of active polypeptides with molecular weights below . It mainly acts on the various stages of lymphocyte differentiation, development and maturation, thereby regulating cellular immune function. It is an immunomodulator that can enhance the body's ability to prevent and resist diseases.
[0004] Lactococcus lactis is a globally recognized safe microorganism with multiple beneficial effects and is often used as a host bacteria for genetic engineering. In the past two decades, Lactococcus lactis has been widely used as a carrier in presenting viruses and bacterial antigens, and has played an important role in different fields. Lactococcus lactis has the ability to colonize the intestines. As a probiotic, it has been proven to be used as a feed additive to improve the intestinal health of animals; as a gene expression engineered bacterium, it can continuously secrete genetically modified functional peptides in the intestines, which are absorbed and utilized by animals.
[0005] Thymosin α1 has good growth promotion effect in pigs, cattle, sheep and poultry feed, increasing protein synthesis rate, improving body metabolism level and enhancing body immunity. He Jia et al. used recombinant L. lactis expressing porcine lactoferrin to feed weaned piglets. The results showed that the piglets' immune organs matured faster, immune function was enhanced, production performance was improved, average daily weight gain was increased, and feed-to-weight ratio was reduced.
[0006] In summary, thymosin α1 and Lactococcus lactis have the effects of promoting growth, enhancing immunity, and improving production performance in animal breeding. Thymosin α1 is generally obtained by tissue extraction and chemical synthesis. However, the tissue extraction method has problems such as high cost, small yield, and difficult purification; although the chemical synthesis method has been optimized and the purity is high, it is expensive and difficult to apply to the breeding industry. Summary of the invention
[0007] The purpose of the present invention is to provide a fusion protein of thymosin α1 and IgY Fc, a recombinant expression vector and an engineered bacterium and their application, which can be used as a feed additive in aquaculture to improve immunity, reduce inflammatory reactions caused by bacteria and the like, and improve survival rate; and the production process is simple, the production cost is reduced, and it has a good market conversion prospect.
[0008] The present invention provides a fusion protein expressing thymosin alpha 1 and IgY Fc.
[0009] Preferably, in the fusion protein, IgY Fc and thymosin α1 are linked by using G4S protein.
[0010] Preferably, the amino acid sequence of the fusion protein is shown in SEQ ID No.1.
[0011] The present invention also provides a recombinant expression vector comprising the coding gene of the fusion protein.
[0012] Preferably, PNZ8149 is used as a backbone plasmid.
[0013] The present invention also provides a recombinant Lactococcus lactis expressing the above fusion protein or comprising the above recombinant expression vector.
[0014] Preferably, Lactococcus lactis NZ3900 is used as the basic strain.
[0015] The present invention also provides the use of the culture of the recombinant Lactococcus lactis as an animal breeding feed additive.
[0016] Preferably, the method for preparing the culture of the recombinant Lactococcus lactis comprises: culturing the recombinant Lactococcus lactis in M17 liquid culture medium, inducing the expression of fusion protein using Nisin, and collecting the bacteria by centrifugation after the induction to obtain the culture.
[0017] Preferably, the recombinant Lactococcus lactis culture is added to the animal feed at a concentration of 1×10 6 ~5×10 7 CFU / g.
[0018] Beneficial effects: The present invention provides a fusion protein expressing thymosin α1 and IgY Fc, and constructs a fusion expression vector of thymosin α1 and IgY Fc fragments, which is the first report of the fusion expression of thymosin α1 and IgY Fc fragments. Compared with simple thymosin α1, it has a longer half-life, and the fusion protein is successfully expressed by using a Lactococcus lactis expression system. Compared with a tissue extraction method, it has the advantages of higher purity, greater convenience, and lower cost, and compared with a chemical synthesis method, it has the advantages of greater safety and lower cost. Compared with a general Escherichia coli expression system, the Lactococcus lactis expression system is safer and does not produce other related toxins, and does not require toxin treatment. In addition, the recombinant Lactococcus lactis has the advantage of intestinal colonization, can be colonized in the intestines of animals, and continuously express and secrete fusion proteins. Lactococcus lactis is a safe beneficial bacterium and is of great significance for regulating intestinal function.
[0019] The present invention also verifies the feasibility of using the fusion protein or recombinant Lactococcus lactis as a feed additive in animal breeding in the embodiments, and can be used as a feed additive in breeding to improve immunity and survival rate, reduce inflammatory reactions and disease incidence caused by bacteria, etc., and increase the economic benefits of the breeding industry; and the production process is simple, the production cost is reduced, and it has a good market conversion prospect. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 This is the result of PCR verification of PNZ8149-Tα1-Fc bacterial solution. The target band is the fragment at 1000 bp; M is the 2000 bp marker, 1, 2, 3: three single clones;
[0021] Figure 2 This is the result of Western blot verification of Tα1-Fc fusion protein expression. The target band is about 26 kDa; M is 180 kDa Marker, 1, 2, 3, 4, 5: Nisin final concentrations are 15 ng / mL, 10 ng / mL, 5 ng / mL, 2 ng / mL, 1 ng / mL, and 6 is empty plasmid PNZ8149 induced expression;
[0022] Figure 3 This is a comparison chart of the body weight of each group during and at the end of the test period of recombinant Lactococcus lactis as a feed additive for pig farming;
[0023] Figure 4 This is a graph showing the effects of recombinant Lactococcus lactis as a feed additive for pig farming on average daily weight gain, average daily feed intake, and feed-to-weight ratio;
[0024] Figure 5This is a graph showing the effect of recombinant Lactococcus lactis on the content of total protein, albumin, globulin, alanine aminotransferase and aspartate aminotransferase in serum indexes when used as a feed additive for pig farming;
[0025] Figure 6 This is a comparison chart of the body weight of each group during and at the end of the test period of recombinant Lactococcus lactis as a feed additive for white-feathered broiler chickens;
[0026] Figure 7 This is a graph showing the effect of recombinant Lactococcus lactis as a feed additive for white-feathered broiler chickens on their average daily weight gain and feed-to-weight ratio;
[0027] Figure 8 The results of the effect of recombinant Lactococcus lactis on the IgG and IgA levels in the serum index of white-feathered broiler chickens at 28 days of age.
[0028] Fig. 9 This is the effect of the amount of recombinant Lactococcus lactis added on the weight of turbot;
[0029] Fig.10 This is a graph showing the effect of recombinant Lactococcus lactis as a feed additive on serum cytokines of turbot;
[0030] Fig.11 This is the result of the effect of recombinant Lactococcus lactis on intestinal protease, lipase and amylase in turbot feed additive;
[0031] Fig.12 This is the result of the effect of recombinant Lactococcus lactis on the survival rate of Penaeus vannamei feed additives;
[0032] Fig.13 This is a graph showing the effect of recombinant Lactococcus lactis as a feed additive on Penaeus vannamei body weight gain and growth rate;
[0033] Fig.14 This is a graph showing the effects of recombinant Lactococcus lactis as a feed additive for white shrimp on its specific growth rate and feed coefficient. DETAILED DESCRIPTION
[0034] The present invention provides a fusion protein expressing thymosin alpha 1 and IgY Fc.
[0035] The thymosin α1 of the present invention is referred to as Tα1, and its GenBank is 770552A, and the Tα1 is connected to the IgY Fc fragment (X07174) through the (G4S)3 protein, and the amino acid sequence of G4S is: GGGGS. The amino acid sequence of the fusion protein of the present invention is shown in SEQ ID No.1.
[0036] The present invention also provides a recombinant expression vector comprising the coding gene of the fusion protein.
[0037] The recombinant expression vector of the present invention preferably comprises PNZ8149 as a backbone plasmid, and the coding gene of the fusion protein is inserted into the PNZ8149. Pst I and XB Before the coding gene of the present invention is connected to the backbone plasmid, it is preferred that the coding gene is optimized according to the codon preference of the subsequent expression strain.
[0038] The present invention also provides a recombinant Lactococcus lactis expressing the above fusion protein or comprising the above recombinant expression vector.
[0039] The present invention preferably uses Lactococcus lactis NZ3900 as the basic strain, and the method for constructing the recombinant Lactococcus lactis preferably includes the following steps: using the above-mentioned recombinant expression vector to transform Lactococcus lactis competent cells to obtain recombinant Lactococcus lactis. The present invention does not specifically limit the transformation method, and the transformation can be carried out using conventional methods in the art.
[0040] The present invention also provides the use of the culture of the recombinant Lactococcus lactis as an animal breeding feed additive.
[0041] The present invention preferably cultured the recombinant Lactococcus lactis in M17 liquid medium, and induced the expression of fusion protein by Nisin, and collected the bacteria by centrifugation after the induction to obtain the culture. The present invention preferably cultured the recombinant Lactococcus lactis in M17 liquid medium (pH 6-7) at 30°C until OD 600 When the value is 0.5, add Nisin inducer with a final concentration of 5-15 ng / mL and continue to culture for 4-6 hours. After the culture is completed, collect the bacterial solution and collect the bacteria by centrifugation.
[0042] The concentration of the culture of the recombinant Lactococcus lactis of the present invention added to animal feed is preferably 1×10 6 ~5×10 7 CFU / g, and the added concentration varies slightly for different animal types. For example, the added concentration in pig feed is preferably 1×10 6 ~1×10 7 CFU / g, more preferably 1×10 6 CFU / g; the concentration added to white-feathered broiler feed is preferably 1×10 6 ~1×10 7 CFU / g, more preferably 5×10 6 CFU / g; the concentration of feed additives added to turbot farming is preferably 5×10 6 ~5×107 CFU / g, more preferably 1×10 7 CFU / g; the concentration of feed additives added to white shrimp farming is preferably 1×10 7 ~5×10 7 CFU / g, more preferably 5×10 7 According to the above addition amount, the recombinant Lactococcus lactis prepared by the present invention can be used as a feed additive in pig farming, white-feathered broiler farming, turbot farming and white shrimp farming to promote the growth rate of the corresponding animals, as well as improve immunity and related intestinal enzyme activities.
[0043] To further illustrate the present invention, the fusion protein of thymosin α1 and IgY Fc, the recombinant expression vector and the engineering bacteria and the application provided by the present invention are described in detail below in conjunction with the examples, but they should not be construed as limiting the scope of protection of the present invention.
[0044] The experimental methods in the following examples where specific conditions are not specified were generally carried out under conventional conditions, such as those described in Molecular Cloning: A Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989) or conditions provided by the manufacturer.
[0045] 1.1 Codon optimization and synthesis of Tα1-Fc
[0046] Optimize the Tα1-Fc nucleotide sequence according to the codon preference of Lactococcus lactis, add a stop codon, and an upstream restriction site Pst I and downstream restriction site XB I. The optimized Tα1-Fc sequence was synthesized into pU19-Tα1-Fc plasmid by Shanghai Shenggong Biotechnology Co., Ltd.
[0047] 1.2 Construction of PNZ8149-Tα1-Fc
[0048] use Pst I and XB I double-digested pU19-Tα1-Fc and PNZ8149, and recovered the digested products to obtain the target fragment Tα1-Fc and the linear vector PNZ8149.
[0049] The target fragment Tα1-Fc and the linear vector PNZ8149 were connected using T4 ligase. A 10 μL reaction system was prepared in a sterile enzyme-free PCR tube: 1 μL Buffer, 1 μL T4 ligase, 1 μL PNZ8149 vector, and 7 μL Tα1-Fc target fragment. After mixing, incubate at 4°C for 12 h.
[0050] 1.3 Preparation of competent lactic acid bacteria
[0051] The preserved Lactococcus lactis NZ3900 was inoculated into M17 liquid culture medium at a ratio of 1:100 and cultured at 30°C for 12 h; then inoculated into M17 liquid culture medium at a ratio of 1:10 and continued to culture at rest for 24 h; then inoculated into M17 liquid culture medium at a ratio of 1:8 and cultured at 30°C until OD 600 The value was 0.4; the bacterial solution was collected and precooled on ice for 30 min; the bacteria were collected by centrifugation at 3000 g for 15 min at 4°C and the precooled buffer 1 (0.5 mol·L −1 Sucrose, 10% glycerol, pH 7) and placed on ice for 20 min; centrifuged again and the precipitate was washed with pre-cooled buffer 2 (0.5 mol·L −1 Sucrose, 10% glycerol, 50mmol·L −1 EDTA, pH 7) and let it stand on ice for 20 min; centrifuge again, resuspend with pre-cooled buffer 1, let it stand on ice for 20 min; centrifuge again, and resuspend the precipitate with 1 mL buffer 1, which is the electroporation competent state.
[0052] 1.4 Electroporation of recombinant vector
[0053] Take 50 μL of freshly prepared NZ3900 competent cells, add 5 μL of ligation product, mix well, quickly add to the pre-cooled electroporation cup, and place it on ice for 5 min; the electroporation instrument settings are: voltage 2000 V, pulse 25 μF, resistance 200 Ω, 5 ms, and after the electroporation, quickly add 37°C preheated M17 preheated culture medium and place it at 30°C for incubation for 1 h.
[0054] 1.5 Positive clone screening
[0055] After incubation, 100 μL was spread on Elliker medium plates, incubated at 30℃ for 24 h, and the color change of the plates was observed. Yellow colonies were picked and inoculated into M17 medium, incubated at 30℃ for 24 h, and the size of positive clones was identified by bacterial liquid PCR. Primer F1 (SEQ ID No.2): 5'-TCTGAAGTTTGTTAGATACAAT-3'; F2 (SEQ ID No.3): 5'-AAGCAACACGTGCTGTAATTTG-3'. The amplification system was: KOD OneTM PCR Master Mix 12.5 μL; F1 (10 μM) 1 μL; R1 (10 μM) 1 μL; bacterial liquid 1 μL; ddH2O 9.5 μL; total 25 μL; amplification program was: 98 ℃ 10 sec; 55 ℃ 5 sec; 68 ℃ 10 sec; 30 cycles. A 2% electrophoresis gel was used to identify the single clone, and the result showed a target band at 1000 bp, indicating that the recombinant expression vector was successfully constructed ( Figure 1 ).
[0056] 2.1 Inducible expression of recombinant strains
[0057] The positive monoclonal recombinant Lactococcus lactis strain was inoculated into M17 liquid medium at a ratio of 1:100 and cultured at 30°C until OD 600 When the value was 0.5, Nisin inducer with a final concentration of 10 ng / mL was added, and static culture was continued for 6 hours. After the culture was completed, the bacterial solution was collected, centrifuged at 5000 g for 10 min, the supernatant was discarded, the bacteria were collected, the bacteria were resuspended with pre-cooled PBS buffer, and centrifuged again; the supernatant was discarded, the precipitate was resuspended with pre-cooled PBS, and the resuspended was centrifuged again; the supernatant was discarded, the bacterial precipitate was resuspended with pre-cooled PBS, and the lysis buffer was added at a volume ratio of 20:1, and the bacterial solution was broken by an ultrasonic disruptor; after the breaking was completed, centrifuged again, and the supernatant was collected.
[0058] 2.2 Identification of Tα1-Fc fusion recombinant protein
[0059] The Tα1-Fc fusion recombinant protein was identified by Western-Blot experiment. Prepare 10% SDS-PAGE electrophoresis gel; mix protein sample and 4× loading buffer in a ratio of 1:3, incubate at 100℃ for 5 min; add 15 μL of the incubated sample to each well; set the concentrated gel voltage to 80 V for 30 min; set the separation gel voltage to 120V for 60 min; cut the PVDF membrane and soak it completely in methanol, transfer it to the transfer clamp, cover the electrophoresis gel on the PVDF membrane, and transfer it to the electrophoresis tank; add ice water mixture to the electrophoresis tank to cool it down, set 200 mA for 60 min; after the transfer, wash the PVDF membrane with PBST, transfer it to a blocking solution of 5% skim milk powder, and incubate it at 37℃ for 2 h; after the blocking is completed, wash the PVDF membrane with PBST, place it in a 1000-fold diluted rabbit anti-thymosin α1 polyclonal antibody, and incubate it at 4℃ for 12 h; after the incubation is completed, wash the PVDF membrane with PBST three times, 10 min each time, and rotate at 60 rpm, and incubate it in 5000-fold diluted goat anti-rabbit polyclonal antibody at room temperature for 1 h; after incubation, wash the PVDF membrane three times with PBST, each time for 10 min, at 60 rpm, treat it with chemiluminescent solution, and observe it with a chemiluminescence instrument. Figure 2 As shown, the target band appeared at 26 kDa, indicating that the recombinant Lactococcus lactis successfully expressed the Tα1-Fc fusion recombinant protein.
[0060] 3.1 Preparation of recombinant Lactococcus lactis
[0061] According to the induction method of "Example 2", the recombinant Lactococcus lactis was induced to express; after the induction was completed, the cells were centrifuged at 3000 g for 10 min, and the cells were collected and resuspended with physiological saline, washed twice, and the bacterial solution was collected for later use.
[0062] 3.2 Grouping and feed configuration
[0063] The commercial three-way nursery pigs used in the experiment were purchased from a standardized pig farm (average 30 kg / head). They were tamed and fed with standard antibiotic-free feed for fattening pigs for two weeks before the experiment. They were divided into 6 groups, each with 10 pigs (1 pen), of which 1 group was the blank control; 2 groups were supplemented with Lactococcus lactis NZ3900 transformed with PNZ8149 empty plasmid, with an addition amount of 5×10 7 CFU / g feed; the recombinant Lactococcus lactis of the present invention was added to groups 3, 4, 5, and 6, and the addition amount was 1×10 6 CFU / g, 5×10 6 CFU / g, 1×10 7 CFU / g, 5×10 7 CFU / g feed. Standardized breeding environment and feeding method.
[0064] 3.3 Sample collection
[0065] The experimental feeding duration was 5 weeks (35 days). The body weight was weighed on the 7th day of each week, and the daily feed consumption was recorded, and the average daily weight gain, average daily feed intake and feed-to-weight ratio were calculated. At the end of the experiment, 2 heads were randomly selected from each group, 5 mL of blood was collected from the anterior vena cava, and the serum was separated and the total protein, albumin, globulin, and alanine aminotransferase and aspartate aminotransferase activities in the serum were determined using an automatic biochemical analyzer.
[0066] 3.4 Results Analysis
[0067] The body weights of groups 3 to 6 supplemented with the recombinant Lactococcus lactis of the present invention were higher than those of groups 1 and 2 during the test period, and the difference was obvious, especially as the feeding time was prolonged, the weight difference became more obvious ( Figure 3 ); The results of analyzing the average daily weight gain, average feed intake and feed-to-weight ratio showed that ( Figure 4 ), the average feed intake and average daily weight gain of groups 3 to 6 during the experimental period were higher than those of groups 1 and 2, and the feed-to-weight ratio was lower than that of groups 1 and 2, and the difference was obvious. The total protein, albumin, globulin, alanine aminotransferase and aspartate aminotransferase of the separated serum were determined, and the results showed that ( Figure 5 ), the total protein, albumin, and globulin contents of groups 3 to 6 were higher than those of groups 1 and 2, and the differences were significant, indicating that the immunity of pigs can be improved; the alanine aminotransferase and aspartate aminotransferase contents of groups 3 to 6 were lower than those of groups 1 and 2, and the differences were significant, indicating that it has a positive effect in reducing animal stress and promoting animal health. Adding recombinant Lactococcus lactis to feed can significantly promote the growth of pigs, improve immunity, increase intestinal digestive enzymes, and improve feed utilization; the comparison results show that adding 1×10 6 CFU / g is more economical.
[0068] The preparation of recombinant Lactococcus lactis is the same as in "Example 3".
[0069] 4.1 Grouping and feed configuration
[0070] The white-feathered broilers used in the experiment were purchased from a standardized breeder farm. They were tamed and fed one week before the experiment. The feed was standard antibiotic-free white-feathered broiler feed. They were divided into 6 groups, with 100 chickens in each group. The blank control was group A; the group B was supplemented with Lactococcus lactis NZ3900 transformed with PNZ8149 empty plasmid, and the addition amount was 5×10 7 CFU / g feed; the recombinant Lactococcus lactis of the present invention was added to groups C, D, E, and F, with the addition amount of 1×10 6 CFU / g, 5×10 6 CFU / g, 1×10 7 CFU / g, 5×10 7CFU / g feed. The standardized stocking density and environment, as well as the feeding method, were simulated, and the feeding amount was adjusted once a week according to the total weight of each group.
[0071] 4.2 Sample collection
[0072] The experimental feeding duration was 33 days, and the feed intake and body weight of broilers were recorded weekly to calculate the average daily weight gain, average daily feed intake and feed-to-meat ratio to determine the effect on the growth performance of white-feathered broilers. On the 28th day of age, 2 mL of blood was collected from the jugular vein of 3 healthy chickens with close to average weight in each group, and serum was prepared and its content was determined using a chicken IgA / IgG indirect enzyme-linked immunosorbent assay (ELISA) kit.
[0073] 4.3 Results Analysis
[0074] The weight of each group of chickens was measured at 7, 14, 21, 28, 35, and 40 days of age. The results showed that the weight of chickens in groups 3 to 6 was higher than that of chickens in groups 1 and 2 ( Figure 6 ); By calculating the average daily weight gain and feed-to-meat ratio, the results showed that the average daily weight gain of groups 3 to 6 was higher than that of groups 1 and 2, and the feed-to-meat ratio was lower than that of groups 1 and 2 ( Figure 7 ). The IgG and IgA levels in the serum of 28-day-old chickens were measured. The results showed that the average daily weight gain of groups 3 to 6 was higher than that of groups 1 and 2, indicating that the addition of recombinant Lactococcus lactis can improve immunity. Adding recombinant Lactococcus lactis to feed can significantly promote the growth of white-feathered broilers and improve immunity; the comparison results show that when the amount of recombinant Lactococcus lactis added to the feed is 5×10 6 The effect was more obvious when the CFU / g
[0075] 5.1 Preparation of recombinant Lactococcus lactis
[0076] According to the induction method of "Example 2", the recombinant Lactococcus lactis was induced to express; after the induction was completed, the cells were centrifuged at 3000 g for 10 min, and the cells were collected and resuspended with physiological saline, washed twice, and the bacterial solution was collected for later use.
[0077] 5.2 Grouping and feed configuration
[0078] The turbot used in the experiment was purchased from a standardized breeding farm and was tamed and fed two weeks before the experiment. The feed was a standard antibiotic-free turbot feed and was divided into 6 groups, with 100 fish in each group. One group was the blank control group; two groups were supplemented with Lactococcus lactis NZ3900 transformed with the PNZ8149 empty plasmid, with an addition amount of 5×10 7 CFU / g feed; the recombinant Lactococcus lactis of the present invention was added to groups 3, 4, 5, and 6, and the addition amount was 1×10 6 CFU / g, 5×10 6 CFU / g, 1×10 7CFU / g, 5×10 7 CFU / g feed. To simulate the standardized stocking density and environment, as well as the feeding method, the daily feed intake was 3% of body weight, and the feed intake was adjusted once every 2 weeks according to the total weight of each group.
[0079] 5.3 Sample collection
[0080] The experimental breeding duration was 60 days. The overall weight of each group of fish was measured in the early morning of the 10th, 20th, 30th, 40th and 60th days, and the average value was calculated. At the end of the experiment, each group fasted for 1 day, and blood was collected from the tail vein to separate the serum. The fish bodies were dissected to observe the morphology and health of the pancreas, intestines, etc., and the intestinal tissue was collected and preserved after quick freezing with liquid nitrogen.
[0081] 5.4 Results Analysis
[0082] The average weights of groups 3 to 6 to which the recombinant Lactococcus lactis of the present invention was added were higher than those of groups 1 and 2, and the differences were obvious, especially as the feeding time was prolonged, the weight difference became more obvious ( Fig. 9 ); The separated serum was tested with a cytokine assay kit to determine the levels of TNF-α, IL-1β, IL-6, IL-12, and IL-10 cytokines. The results showed that the levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-12) and anti-inflammatory cytokines (IL-10) in groups 3 to 6 were higher than those in groups 1 and 2, and the differences were significant ( Fig.10 After grinding the intestinal tissue, the supernatant was taken and the activity of protease, lipase and amylase was tested using a digestive enzyme activity assay kit. The results showed that the values of protease, lipase and amylase in groups 3 to 6 were higher than those in groups 1 and 2, and the differences were significant ( Fig.11 ); Through observation of the intestine and pancreas after dissection, the intestine of the experimental group was healthier than that of the control group. Adding recombinant Lactococcus lactis to the feed can significantly promote the growth of turbot, improve immunity, increase intestinal digestive enzymes, and improve feed utilization; the comparison results show that when the feed is added with a dosage of 1×10 7 CFU / g is more economical.
[0083] The preparation of recombinant Lactococcus lactis is the same as in "Example 3".
[0084] 6.1 Grouping and feed configuration
[0085] The white shrimp used in the experiment were purchased from a standardized shrimp farm. They were tamed and fed two weeks before the experiment. The feed was standard antibiotic-free white shrimp feed. They were divided into 6 groups, with 200 shrimp in each group. The blank control was group A; the group B was supplemented with Lactococcus lactis NZ3900 transformed with PNZ8149 empty plasmid, and the addition amount was 5×10 7CFU / g feed; the recombinant Lactococcus lactis of the present invention was added to groups C, D, E, and F, with the addition amount of 1×10 6 CFU / g, 5×10 6 CFU / g, 1×10 7 CFU / g, 5×10 7 CFU / g feed. To simulate the standardized stocking density and environment, as well as the feeding method, the daily feed intake was 3% of body weight, and the feed intake was adjusted once every 2 weeks according to the total weight of each group.
[0086] 6.2 Sample collection
[0087] The experimental feeding duration was 60 days. At the end of the experiment, each group fasted for 1 day, and 40 shrimps were randomly selected from each group to measure the total length and weight. The survival rate, weight gain rate, specific growth rate and feed coefficient of each group of experimental shrimp were calculated. Survival rate (%) = (total number of surviving experimental shrimps at the end of the experiment / total number of shrimps at the beginning of the experiment) × 100; weight gain rate (%) = (FBW-W0) / W0×100; specific growth rate (% / d) = 100×(ln FBW-ln W0) / T; feed coefficient (%) = feed feeding amount (g) / body weight increase (g); where W0 represents the initial total weight of each group of shrimp; FBW represents the final body weight of each group of surviving shrimps at the end of the experiment (converted to the body weight at the beginning of the experiment according to the survival rate); T represents the duration of the experiment, 60 days.
[0088] 6.3 Results Analysis
[0089] After the experiment, the survival rate of each group of shrimp was calculated. The results showed that the survival rate of groups C to F was higher than that of groups A and B, and the survival rate of group F was the highest ( Fig.12 The average weight and length of shrimp were weighed, and the final weight, weight increment and weight increment rate were calculated. The results showed that the weight increment of groups C to F was higher than that of groups A and B ( Fig.13 ); Calculate the specific growth rate and feed coefficient. Similarly, groups C to F are better than groups A and B ( Fig.14 Adding recombinant Lactococcus lactis to feed can significantly promote the growth of white shrimp and improve feed utilization. 7 The effect was more obvious when the CFU / g
[0090] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.
Claims
1. Use of a culture of recombinant Lactococcus lactis expressing a fusion protein of thymosin α1 and IgY Fc as an animal feed additive, characterized in that: The method for preparing the culture of the recombinant Lactococcus lactis comprises: culturing the recombinant Lactococcus lactis in an M17 liquid culture medium, inducing the expression of the fusion protein using Nisin, and collecting the bacteria by centrifugation after the induction is completed to obtain the culture; The amino acid sequence of the fusion protein is shown in SEQ ID No.
1.
2. The application according to claim 1, characterized in that: The recombinant Lactococcus lactis culture is added to the animal feed at a concentration of 1×10 6 ~5×10 7 CFU / g.
